Drugs / VitaE
last change Mar 2021 re-read 2 minutes ago

VitaE

Developed for
breast fibrocystic disease

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04694027 Comparator Jan → Mar 2021 breast fibrocystic disease Cairo University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as VitaE ClinicalTrials.gov intervention name — accepted as the source's own label NCT04694027